New hepatitis C medications are allowing people to receive a kidney transplant from a deceased donor who had the liver disease -- a strategy aimed at getting more lifesaving organs to patients languishing on waitlists.
Two new studies are highlighting the promise of the approach, showing that if patients are given the drug Mavyret, they can safely receive the kidneys and the organs fu...
Taking the hepatitis C drugs Mavyret, Zepatier or Vosevi can trigger rare cases of severe liver problems or liver failure in patients who already have moderate-to-severe liver impairment, the U.S. Food and Drug Administration warned Wednesday.
The agency has identified 63 cases of worsening liver function, some resulting in liver failure or death, among patients taking the drugs.
Patients in dire need of an organ transplant can safely receive a new heart or lung from donors who have hepatitis C, a new clinical trial has shown.
By swiftly administering powerful antiviral drugs, doctors can prevent the organ recipient from contracting hepatitis C following their transplant, said lead researcher Dr. Ann Woolley. She's an infectious disease doctor with Brigham and...
More than 70,000 lives were lost to drug overdoses in the United States in 2017. Now, some of those touched by these tragedies might take a little comfort knowing their loved one's heart helped save a life.
Nearly 18 percent of hearts recovered for organ transplant in 2017 came from people who had died of drug intoxication. That number was up from 1.5 percent in 1999.
An effort to make the opioid painkiller OxyContin harder to abuse drove addicted patients to heroin and caused a dramatic increase in hepatitis C, a new study suggests.
In a classic case of unintended consequences, Connecticut-based Purdue Pharma reformulated its powerful and popular drug OxyContin for the right reasons. It became harder to crush or dissolve, thus making it harder to...
Millions of hepatitis C cases and related deaths could be prevented, but it will require a significant investment, researchers say.
In the first study to model such measures worldwide, the authors concluded that sweeping prevention, screening and treatment efforts could prevent 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths by 2030.
A large number of U.S. cancer patients with hepatitis B and C don't know they have the virus, which can cause life-threatening complications during some cancer treatments, researchers say.
The findings suggest screening for hepatitis B and C may be appropriate in community cancer clinics, according to investigators from the SWOG Cancer Research Network, an international group funded b...
Add another hardship to the many already triggered by the opioid epidemic: More donated organs infected with the hepatitis C virus.
"The ongoing U.S. opioid crisis has resulted in an increase in drug overdose deaths and acute hepatitis C virus infections, with young persons (who might be eligible organ donors) most affected," explained a team led by Dr. Winston Abara. He's a hepatitis...
The percentage of U.S. liver transplant recipients with alcohol-associated liver disease (ALD) doubled over 15 years, but significant regional variations remain, a new study finds.
ALD has replaced hepatitis C as the most common reason for U.S. liver transplants. One reason is that hepatitis C rates have decreased due to antiviral therapy. But a more likely cause for the change is the...
If you have diabetes, you need all recommended vaccinations, the American Association of Diabetes Educators says.
Diabetes reduces the immune system's ability to fight certain infections. This raises the risk for serious complications from diseases that vaccines protect against -- including flu, pneumonia, hepatitis B, tetanus and shingles.
Dialysis patients waiting for kidney transplants might safely accept an organ from a donor infected with hepatitis C virus (HCV), a new study finds.
Using hepatitis C-infected kidneys would expand the organ pool and save lives, said lead researcher Dr. Peter Reese. He's an associate professor of medicine at the University of Pennsylvania School of Medicine in Philadelphia.